Avadel Pharmaceuticals plc Ordinary Share (AVDL) Stock Price, Quote & AI Analysis
Live AVDL stock price, real-time charts, AI-powered trade signals, technical analysis, earnings insights, and market sentiment for Avadel Pharmaceuticals plc Ordinary Share.
TradeVae provides AI-driven analysis and real-time market intelligence for Avadel Pharmaceuticals plc Ordinary Share (AVDL), including price action, technical indicators, earnings performance, analyst sentiment, and short-term trade setups.
AI Analysis
Explore comprehensive AI-powered analysis including summary insights, bull and bear cases, key risks, and factors to watch.
Generating AI analysis...
Avadel Pharmaceuticals plc Ordinary Share's fundamentals reflect its scale, profitability, and position within the global technology sector. Key valuation and financial metrics are summarized below, followed by detailed financial statements.
Avadel Pharmaceuticals plc Ordinary Share Overview
Company information
Company Overview
Avadel Pharmaceuticals Plc engages in the development and commercialization of pharmaceutical products. Its main product is LUMRYZ is an extended-release formulation of sodium oxybate, which used in the treatment of cataplexy or EDS in adults with narcolepsy. The company was founded on July 21, 1990 and is headquartered in Dublin, Ireland.
Company Details
Technical Indicators
Key technical analysis metrics and signals
Loading technical indicators...
Valuation Metrics
Key valuation ratios and comparisons
Loading valuation metrics...
Avadel Pharmaceuticals plc Ordinary Share Earnings & Financial Statements
Earnings Calendar
Upcoming earnings dates and historical surprises
Loading earnings calendar...
Financial Statements
Income statements, balance sheets, and cash flow
Loading income statements...
Loading balance sheets...
Loading cash flow statements...